Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Shares of Hims & Hers tumbled 12% in after-hours trading Monday after the company's second-quarter revenue missed Wall Street ...

Consensus analyst estimates for Novo Nordisk (NVO) earnings per share and revenue land at $0.92 and $11.9 billion, ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

Wall Street looks to stabilise after last week’s tariff-driven slump, with investors gearing up for a crucial week packed ...

Tesla has awarded its chief executive a “first step payment worth roughly $29 billion to replace a plan blocked by a Delaware ...

In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart.

Stocks surged Monday, led by tech sector gains, as the market recovered from a steep decline at the end of last week that was sparked by renewed concerns about tariffs and the health of the economy.

We came across a bullish thesis on Hims & Hers Health, Inc. on The Musings of Ozz’s substack by Christopher De Ozz. In this ...

Increases full-year guidance BIRMINGHAM, Ala., Aug. 4, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC ), the large ...